Home / Conditions / Knee Problem Pain
Knee Problem Pain: when insurers say no, reviewers often say yes
In 376 published external-review decisions involving knee problem pain, independent physician reviewers overturned the insurer’s denial 64.1% of the time.
Published decisions
376
2001–2026
Overturned
64.1%
241 denials reversed
Most-fought treatments for knee problem pain
What insurers denied — and how those fights ended.
| Category | Decisions | Overturned |
|---|---|---|
| Viscosupp Injection | 168 | 95.2% |
| MRI | 40 | 52.5% |
| Arthroscopy | 26 | 50% |
| Knee Replacement | 20 | 15% |
| Physical Therapy | 16 | 12.5% |
| Nerve Block | 11 | 72.7% |
| Radiofreq Ablat | 7 | 42.9% |
| Pain Medication | 7 | 42.9% |
| Ligament Tendon Repair | 5 | 60% |
What the insurer actually argued
Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
| Reason given | Decisions | Overturned |
|---|---|---|
Medical Necessity The plan said the care wasn’t medically necessary. The most common fight, and the most winnable. | 312 | 70.8% |
Experimental/Investigational The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument. | 62 | 30.6% |
Typical time to a decision
7 days
Most land between 4 and 20 days
Handled as urgent
57.7%
Expedited when a delay would cause harm
Recent direction
Rising
60% → 68.8% overturned, last three years
What the reviewers wrote
Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.
Where the denial was overturned
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for magnetic resonance imaging (MRI) of the left knee. The European Alliance of Associations for Rheumatology (EULAR) recommends the use of imaging in the clinical management of peripheral joint osteoarthritis for atypical clinical presentations. Imaging helps to confirm the diagnosis of osteoarthritis and make alternative or additional diagnoses. The clinical guidelines for imaging of knee osteoarthritis indicate that if imaging is needed, X-rays should be used before other modalities. However, in a review of current evidence and clinical guidelines, the authors noted that knee X-rays for osteoarthritis are associated with substantial drawbacks including low sensitivity and poor clinical correlation.
Nature of Statutory Criteria/ Case Summary: The enrollee is requesting authorization and coverage for Contrave TAB.The enrollee has a history of obesity, class I, with a body mass index (BMI) of 30-34.9, papillary thyroid carcinoma and post-surgical hypothyroidism. Her weight increased from 158 pounds (BMI 29.01) to 172 pounds (BMI 31.55). While this weight gain could be attributed to her hypothyroidism, as lab results showed elevated TSH this was not currently the case. Lab results showed a TSH level of 0.57 (within the normal range of 0.40-4.50), and the provider documented the enrollee was euthyroid, and should continue on the current thyroid replacement regimen of levothyroxine. Despite the enrollee’s euthyroid state, records indicate her weight gain could not be controlled with a low carbohydrate diet and lifestyle modification.
Where the denial was upheld
Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has requested reimbursement for magnetic resonance imaging of left heel and left knee. Findings: The physician reviewer found that The patient denied plantar fasciitis pain with palpation. Researchers explain, “Advanced imaging modalities, including computed tomography, magnetic resonance imaging (MRI), and dynamic fluoroscopic imaging, allow for a comprehensive evaluation of the knee joint. Compositional sequences for MRI can allow for an evaluation of the biochemical properties of cartilage, meniscus, and ligament that offer further insight into pathology that may not be apparent on conventional clinical imaging.
Nature of Statutory Criteria/Case Summary: The patient’s parent has requested authorization and coverage for medial patellofemoral ligament (MPFL) reconstruction.Findings: The physician reviewer found that “MPFL reconstruction and medial patellofemoral soft-tissue surgery procedures were both effective in restoring the medial restraining forces preventing redislocation, but MPFL reconstruction provided better functional outcomes both at short-term and long-term follow-up. Thus, besides the treatment of predisposing factors, MPFL reconstruction seems to be, based on the results of this meta-analysis, a suitable strategy to restore the medial restraining function in the treatment of recurrent lateral patellar dislocation.” Hopper and colleagues explain, “The MPFL is the main restraining force against lateral patellar displacement. It is disrupted after patellar subluxation or dislocation.
Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California outcomes — every state runs an equivalent external review, but the rates here are California’s. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.
How to use this in your appeal
These outcomes come from California’s external review program — an independent physician panel whose decision binds the insurer. Every state has an equivalent, and internal appeals succeed even more often. If your care for knee problem pain was denied, the published record says the denial is worth fighting.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.